European Archives - Page 4 of 1076 - European Medical Journal

One-Third of Women With Lupus Suffer From Depression

A new study reveals high rates of depression and fibromyalgia in Jordanian women with lupus, calling for an integrated approach to managing both physical and psychological aspects of the disease.

Depression Tied to Higher Metabolic Risk in Women With PCOS

A new long-term study finds that women with PCOS and a history of depression or anxiety are at greater risk of developing metabolic syndrome, underscoring the need for integrated mental and metabolic health care.

Immunotherapy Boosts Chemotherapy Efficacy in Early-Stage Breast Cancer

Nivolumab enhances chemotherapy efficacy in high-risk ER+/HER2− breast cancer, offering new treatment potential for early-stage patients.

Sanofi's chlamydia vaccine fast-tracked by FDA

This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.

Childhood Tuberculosis on the Rise in Europe: Call to Action

The ECDC reports an alarming 10% rise in childhood tuberculosis cases across Europe, stressing the urgent need for enhanced prevention, diagnosis, and treatment.

Higher Calcium Intake Linked to Reduced Colorectal Cancer Risk

New findings from a decades-long study of over 470,000 adults show that higher calcium intake may significantly reduce the risk of colorectal cancer, regardless of whether it comes from dairy, non-dairy foods, or supplements.

Spesolimab: A Breakthrough in Treating Generalised Pustular Psoriasis

Spesolimab, a monoclonal antibody targeting the interleukin (IL)-36 receptor, has been approved as the first GPP-specific therapy.

Cartoon brain on green background

New study shines light on dementia in the workplace

A new study is challenging the belief that dementia is incompatible with modern work environments, with AI helping employees stay in work.

Reducing Body Weight and Fat in HFpEF with a Controlled Metabolic Accelerator

Novel metabolic accelerator HU6 reduces fat mass without muscle loss in obesity-related heart failure patients.

GLP-1 Use After Kidney Transplant Linked to Nearly 50% Lower Graft Loss

GLP-1 receptor agonists were associated with nearly 50% lower graft loss and significantly reduced mortality in kidney transplant recipients with diabetes, according to new research.